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ABSTRACT
Objectives Studies in rheumatoid arthritis (RA),
osteoarthritis (OA) and mice with arthritis demonstrated
tyrosine hydroxylase-positive (TH+) cells in arthritic
synovium and parallel loss of sympathetic nerve ﬁbres.
The exact function of TH+ cells and mode of TH
induction are not known.
Methods Synovial cells of RA/OA were isolated and
cultured under normoxic/hypoxic conditions with/without
stimulating enzyme cofactors of TH and inhibitors of TH.
We studied TH expression and release of cytokines/
catecholamines. In vivo function was tested by cell
therapy with TH+ neuronal precursor cells (TH+ neuronal
cells) in DBA/1 mice with collagen type II-induced
arthritis (CIA).
Results Compared with normoxic conditions, hypoxia
increased TH protein expression and catecholamine
synthesis and decreased release of tumour necrosis
factor (TNF) in OA/RA synovial cells. This inhibitory effect
on TNF was reversed by TH inhibition with α-methyl-
para-tyrosine (αMPT), which was particularly evident
under hypoxic conditions. Incubation with speciﬁc TH
cofactors (tetrahydrobiopterin and Fe2+) increased
hypoxia-induced inhibition of TNF, which was also
reversed by αMPT. To address a possible clinical role of
TH+ cells, murine TH+ neuronal cells were generated
from mesenchymal stem cells. TH+ neuronal cells
exhibited a typical catecholaminergic phenotype.
Adoptive transfer of TH+ neuronal cells markedly reduced
CIA in mice, and 6-hydroxydopamine, which depletes
TH+ cells, reversed this effect.
Conclusions The anti-inﬂammatory effect of TH+
neuronal cells on experimental arthritis has been
presented for the ﬁrst time. In RA/OA, TH+ synovial cells
have TH-dependent anti-inﬂammatory capacities, which
are augmented under hypoxia. Using generated TH+
neuronal cells might open new avenues for cell-based
therapy.
INTRODUCTION
During the last two decades, neuroendocrine-
immune interactions became more and more
relevant in understanding pathophysiology of
rheumatic diseases.1–5 For example, the actual
target of inﬂammation in rheumatoid arthritis (RA),
the synovial tissue, is strongly affected by the sym-
pathetic nervous system depending on the phase of
inﬂammation. In the early acute phase of experi-
mental arthritis, the sympathetic nervous system
has a pro-inﬂammatory role,6–8 whereas in the late
chronic phase anti-inﬂammatory effects have been
described.8 At the beginning of the chronic phase,
the loss of sympathetic nerve ﬁbres in synovial
tissue was reported, which is paralleled by appear-
ance of tyrosine hydroxylase-positive (TH+)
catecholamine-producing cells.9–12 Recently, these
TH+ cells of RA and osteoarthritis (OA) patients
have been shown to exhibit anti-inﬂammatory
properties in vitro.9 However, important cofactors
and inducers of this catecholamine-producing
enzyme have never been studied and the role of
TH+ cells in vivo is not known yet.
TH is regulated by the phosphorylation status of
subunits,13 14 environmental pH value,15 speciﬁc
stimulatory cofactors such as tetrahydrobiopterin
(BH4) and bivalent iron (Fe
2+),13 16 product feedback
inhibition, and proteasomal degradation.17 In add-
ition, hypoxia was shown to enhance TH gene
expression, TH mRNA stability and TH activity by
increasing phosphorylation of TH.18 19 Inﬂammation
is accompanied by hypoxia;20 hypoxia plays an
important role in disease progression in RA.21–23
Under these considerations, we expected that
hypoxia inﬂuences expression and activity of TH in
chronically inﬂamed tissue. This might result in
enhanced catecholamine synthesis of TH+ cells,
which in turn might affect inﬂammatory cytokine
production in vitro.
In order to study TH+ cell effects in vivo, treat-
ment of arthritic animals with TH+ cells is manda-
tory. To our knowledge, TH+ cells do not express
suitable surface markers to separate these cells by
respective sorting techniques demanding a different
strategy. Human TH+ cells expressing speciﬁc
markers such as TH, β-III-tubuline (neuronal intra-
cellular scaffold protein), vesicular monoamine
transporter 2 (VMAT-2) and nuclear receptor
related 1 (Nurr1) protein have been generated on
the basis of mesenchymal stem cells (MSCs).24 25
These cells are TH+ neuronal precursor cells
(called TH+ neuronal cells). However, no similar
differentiation experiments have been performed to
generate TH+ neuronal cells in rodents, and these
cells have not been used in experimental arthritis in
mice or in other disease models.
The aim of these studies was to investigate
hypoxia-induced effects on TH expression, cat-
echolamine release and inﬂammatory cytokine
release in RA/OA human synovial cells in vitro. TH
cofactors (BH4 and Fe
2+) were used to amplify the
function of TH, and cytokine release was
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investigated. In addition, TH+ neuronal cells were generated
from murine MSCs in order to perform adoptive transfer
experiments during collagen type II-induced arthritis (CIA) in
mice. Effects of adoptively transferred TH+ neuronal cells were
studied under treatment with 6-hydroxydopamine (6OHDA) to
kill TH+ cells.
MATERIALS AND METHODS
Human samples were collected with informed consent of the
involved individuals, and mouse experiments were performed in
accordance with local institutional and governmental regulations
for animal use. The project was approved by the Ethics
Committee of the University of Regensburg. A more complete
and detailed description of the methods is included in online
supplementary SI materials and methods.
Human synovial cell culture
Human mixed synoviocytes were incubated under hypoxic and
normoxic conditions for 24 h with speciﬁc TH cofactors BH4
(6R-5,6,7,8-tetrahydrobiopterin dihydrochloride), bivalent
iron (Fe2+ sulfate heptahydrate), α-methyl-para-tyrosine (αmpT;
a competitive TH blocker), monoaminooxidase (MAO)
inhibitor bifemelane hydrochloric acid (HCL) and catechol-O-
methyltransferase (COMT) inhibitor OR-486 at indicated
concentrations. Supernatant was collected and concentrations of
interleukin (IL)-6, IL-8 and tumour necrosis factor (TNF) were
determined by ELISA or Luminex technology. For catecholamine
determination high pressure liquid chromatography (HPLC) was
performed. Expression of TH was analysed by immunocyto-
chemistry in chamber slides and via western blotting.
Mouse experiments
Murine bone marrow-derived stem cells (MSCs) were isolated
from bone chips of DBA/1J mice, expanded and characterised.
Catecholaminergic induction was initiated with a speciﬁc cate-
cholaminergic cocktail. Generated TH+ neuronal cell character-
isation was performed by light and immunoﬂuorescence
microscopy, western blotting, HPLC and using 6OHDA, which
destroys TH+ cells speciﬁcally. For adoptive transfer, TH+ neur-
onal cells were intravenously injected into the tail vein of DBA/
1J mice with collagen-induced arthritis when an arthritis score
of 10 was reached. Clinical arthritis score was determined until
day 55 after immunisation. In another experiment, catecholami-
nergic cells were labelled using the red ﬂuorescent PKH26 in
order to characterise localisation of cells in the body of mice.
Sections of organs and paws were screened for labelled cells by
ﬂuorescence microscopy. In a further set of experiments, begin-
ning on day 10 after TH+ neuronal cell adoptive transfer,
6OHDAwas injected intraperitoneally on three consecutive days
and clinical arthritis score was determined in order to follow-up
the role of injected TH+ neuronal cells.
RESULTS
Hypoxia induces TH in mixed synovial cells
Hypoxic conditions compared with normoxia induced TH
protein expression in both OA and RA cell cultures (ﬁgure 1A).
This observation was conﬁrmed by western blotting because
Figure 1 Effects of hypoxia on tyrosine hydroxylase (TH) expression and cytokine release in synovial cells of patients with osteoarthritis (OA) and
rheumatoid arthritis (RA). (A) Immunoﬂuorescent detection of TH-positive synovial cells after 24 h of normoxic or hypoxic incubation (Bar 100 mm).
(B) Western blot analysis of TH expression in synovial cells from OA and RA patients after 24 h of normoxic or hypoxic incubation (see also
supplementary ﬁgure 2). (C) Quantiﬁcation of released cytokines in supernatants of synovial cells from OA and RA patients after 24 h of normoxic or
hypoxic incubation (n=21–44). Data are presented as box plots, where the boxes represent the 25th to 75th percentiles, the lines within the boxes
represent the median, and the lines outside the boxes represent the 10th and 90th percentiles. The red boxes represent hypoxic conditions. Values are
demonstrated in per cent of the normoxic control (untreated normoxic control=100%, broken line). adr. gl, adrenal gland; no, normoxia; ho, hypoxia.
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after 24 h under hypoxic conditions, total TH was increased
compared with normoxic conditions (ﬁgure 1B).
Hypoxia-dependent TH induction inﬂuences inﬂammatory
cytokine release
Incubation of mixed synovial cells under hypoxic conditions
resulted in an altered inﬂammatory cytokine release pattern
compared with normoxic incubation (ﬁgure 1C). In OA synovial
cells, each analysed cytokine (IL-6, IL-8 and TNF) was signiﬁ-
cantly reduced by hypoxia (ﬁgure 1C). In contrast, in RA syn-
ovial cells, IL-6 and IL-8 increased signiﬁcantly after hypoxic
incubation, whereas TNF was signiﬁcantly reduced similar to
OA synovial cells (ﬁgure 1C).
Involvement of TH in these observed effects was tested using
the competitive TH inhibitor αmpT, which was able to reverse
hypoxia-mediated TNF reduction signiﬁcantly at 1 μg/mL in
both OA and RA synovial cell cultures (ﬁgure 2A). In OA syn-
ovial cells under normoxic conditions, αmpT at 0.1 μg/mL also
increased TNF (ﬁgure 2A). In the case of RA cells, the 1 μg/mL
concentration of αmpT was able to signiﬁcantly increase TNF
under normoxic conditions (ﬁgure 2A). The dose–response
curve has a bell-shaped form, which can be due to toxic/unspe-
ciﬁc effects at 10 mg/mL (ﬁgure 2A).
Speciﬁc TH cofactors enhance hypoxia-mediated
effects on cytokines
In order to further increase TH activity, speciﬁc TH cofactors
such as BH4 and Fe
2+ were added. In combination (BH4 0.1 mM
and Fe2+ 10 nM), these cofactors enhanced hypoxia-mediated
effects on IL-6 and TNF in both OA and RA synovial cell cultures
(ﬁgure 2B): In OA cell culture, IL-6 decreased from 85% of the
normoxic control to 60% and TNF declined from 90% to 80%.
In RA synovial cells, IL-6 rose from 110% of the normoxic
control to 140% and TNF decreased from 85% to 75%
(ﬁgure 2B). In OA synovial cells, 0.1 mM BH4 and 10 nM Fe
2+
exhibited inhibitory effects on IL-6 also under normoxia (ﬁgure
2B). All these described effects caused by BH4 and Fe
2+ were
reversed by the competitive TH inhibitor αmpT (ﬁgure 2B).
Figure 2 Modulation of inﬂammatory cytokine release of synovial cells by tyrosine hydroxylase (TH) cofactors and a TH inhibitor in synovial cells
of patients with osteoarthritis (OA) and rheumatoid arthritis (RA). (A) Reversion of hypoxia-mediated TNF inhibition by the competitive TH inhibitor
α-methyl-para-tyrosine (αmpT, n=6–44). (B) Inﬂuence of the two TH cofactors tetrahydrobiopterin (BH4) and Fe
2+ on release of IL-6 and TNF with/
without αmpT (n=9–10). Box plots are explained in legend to ﬁgure 1. The red (white) boxes show hypoxic (normoxic) conditions. Data points are
presented as per cent of the untreated normoxic control group (untreated normoxic control=100%, broken line).
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Catecholamine biosynthesis in synovial cell culture
The effect of catecholamines on TNF release demonstrated
above might be stronger in the presence of inhibitors of
catecholamine-degrading enzymes (MAO and COMT inhibi-
tors). Under hypoxic conditions, MAO and COMT inhibitors
enhanced TNF inhibition signiﬁcantly in both OA and RA syn-
ovial cell culture (ﬁgure 3A). The same MAO and COMT
inhibitor-dependent effect was observed under normoxic condi-
tions (ﬁgure 3A).
A good indication of TH activity is the release of catechola-
mines into the supernatant. Using both OA and RA cells, con-
centration of catecholamines in cell supernatants incubated
under normoxia was at the detection limit. Under hypoxia,
higher catecholamine levels were measured (approximately
10−9–10−8 M, ﬁgure 3B).
The coincubation with MAO and COMT inhibitors resulted in
catecholamine accumulation. After 24 h of hypoxic incubation,
higher catecholamine concentrations were detected compared
with normoxia or to supernatants without MAO and COMT
inhibitors in both OA and RA synovial cell cultures (ﬁgure 3B).
Catecholaminergic differentiation of murine MSCs
Until now, we were not able to demonstrate a direct anti-
inﬂammatory effect of TH+ cells in experimental arthritis
because TH+ cells cannot be separated by magnetic or ﬂuores-
cent sorting techniques. Thus, we decided to generate TH
expressing cells from MSCs in mice to treat animals with CIA.
Cells from murine bone chips that proliferated until passage 4
exhibited ﬁbroblast-like morphology (ﬁgure 4A,B,F) and a
MSC-speciﬁc surface marker pattern (see online supplementary
ﬁgure S1). In addition, these cells were able to differentiate into
adipocytes (ﬁgure 4C), osteocytes (ﬁgure 4D) and chondrocytes
(ﬁgure 4E) in cell linage-speciﬁc differentiation media.
After 12 days of catecholaminergic differentiation, induced
TH+ neuronal cells were compared with MSCs morphologically
and immunocytologically. In contrast to MSCs, induced TH+
neuronal cells expressed neuronal precursors and showed
neuron-like morphology (ﬁgure 4F). Differentiated TH+ neur-
onal cells formed cell-connected rosette-like patterns, which is
characteristic for neurogenic differentiation.26 While MSCs
were deﬁnitely negative for catecholaminergic markers such as
Figure 3 Catecholamine and TNF release of synovial cell cultures of patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Box plots are
explained in legend to ﬁgure 1. (A) Enhanced TNF inhibition due to catecholamine accumulation caused by treatment of synovial cells with MAO
and COMT blockers (each 10−5 M; n=6–44). The red (white) boxes in (A) show hypoxic (normoxic) conditions. Values in (A) are demonstrated in %
of the normoxic control (untreated normoxic control: 100%, broken line). (B) Catecholamine levels (NE, norepinephrine; DA, dopamine) in
synoviocyte supernatants after 24 h of normoxic or hypoxic incubation (n=6–7). SCm, medium without cells; no, normoxia; ho, hypoxia; no+B,
normoxia plus blockers of monoamino oxidase (MAO, bifemelane 10−5 M) and catechol-O-methyl-transferase (COMT, OR-486 10−5 M); ho+B,
hypoxia plus MAO and COMT blockers.
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βIII-tubulin, TH, VMAT-2 and Nurr1 (ﬁgure 4F), induced TH+
neuronal cells clearly expressed all these catecholaminergic
markers (ﬁgure 4F).
In MSC culture supernatants, catecholamine concentrations
were below the detection limit (approximately 10−9 M, ﬁgure 5A).
At day 7 of catecholaminergic differentiation, that is, shortly before
brain-derived neurotrophic factor (BDNF) supplementation, cells
secreted catecholamines leading to concentrations of up to 10−8 M
(ﬁgure 5A). On day 12, catecholamine concentrations increased to
10−7 M (ﬁgure 5A). While both norepinephrine and dopamine
were measured (ﬁgure 5A), epinephrine was not measurable.
In order to study whether 6OHDA can deplete induced TH+
neuronal cells in vitro, 6OHDA was incubated together with
these cells. After 24 h 6OHDA treatment, no vital induced TH+
neuronal cells were detected in chamber slides (ﬁgure 5B, red
colour=dead cells). In contrast, almost 100% of MSCs survived
6OHDA treatment (ﬁgure 5B, green colour=vital cells).
High TH expression of induced TH+ neuronal cells was con-
ﬁrmed by western blotting (ﬁgure 5C). After 12 days of catecho-
laminergic differentiation, induced TH+ neuronal cells showed
high TH expression, whereas TH was not detected in MSC
(ﬁgure 5C). β-Actin expression was not affected during catecho-
laminergic differentiation (ﬁgure 5C).
Cell therapy with induced TH+ neuronal cells in
experimental arthritis
To investigate the inﬂuence of in vitro-induced TH+ neuronal
cells, these cells were adoptively transferred to animals with
CIA. MSC- and PBS-treated mice were used as controls.
We studied tissue distribution of injected PKH26-labelled
TH+ neuronal cells. After 24 h, induced TH+ neuronal cells
were detected in paw joints, lymph nodes, spleen and adrenal
gland (ﬁgure 6A). No labelled TH+ neuronal cells were found
in brain, lung, heart, digestive organs or in kidneys.
CIA appeared on day 19–21 after immunisation, and score 10
was reached on day 22–25 after immunisation (ﬁgure 6B).
Clinical arthritis scores of control mice showed a characteristic
progression with strong increase between day 22 and 38 after
immunisation and a maximum mean score of 25 score points on
day 35–38 (ﬁgure 6B). In contrast, mice treated with 1 million
induced TH+ neuronal cells developed a signiﬁcantly milder
arthritis (ﬁgure 6B, p=0.025 for comparison vs controls using
general lineal model). Treatment effects of induced TH+ neur-
onal cells were observed from day 10 after adoptive transfer and
a marked difference versus control animals remained until the
end of observation (day 30 after one-shot cell treatment). MSC
treatment also resulted in a milder but not signiﬁcantly amelio-
rated arthritis (see online supplementary ﬁgure S3A, p=0.222
for comparison vs controls using general linear model).
The H&E staining of cryo-sections showed a higher number
of cell nuclei in synovial tissue in phosphate-buffered saline
(PBS) injected control paws. In contrast, in sections of MSC- or
TH+ neuronal cell-treated paws cell inﬁltration was less pro-
nounced (see online supplementary ﬁgure S4).
Since 6OHDA treatment induced a strong pro-inﬂammatory
increase in late CIA,8 and since 6OHDA can deplete induced
TH+ neuronal cells in vitro (ﬁgure 5B), we hypothesised that
injection of 6OHDA increases arthritis severity in animals
Figure 4 Characterisation of murine mesenchymal stem cell (mMSCs)-derived tyrosine hydroxylase-positive (TH+) neuronal cells. (A and B) mMSCs
migrating from bone chips (A, magniﬁcation 100×) and proliferating in plastic ﬂasks (B, magniﬁcation 200×). (C–E) Multilineage differentiation of
mMSCs to adipocytes (C, magniﬁcation 400×), osteoblasts (D, magniﬁcation 100×) and chondrocytes (E, magniﬁcation 40×). (F) Characterisation of
TH+ neuronal cells compared with mMSCs using phase contrast microscopy (200×), and antibodies to βIII-tubulin, TH, vesicular monoamine
transporter 2 (VMAT-2), nuclear receptor related 1 (Nurr1). Magniﬁcations: 200×. TH+ NC, TH+ neuronal cells.
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treated with TH+ neuronal cells. Indeed, intraperitoneal injec-
tion of 6OHDA 10 days after adoptive transfer resulted in a
short initial fall followed by a steady increase of arthritis scores
until day 30 after cell treatment (ﬁgure 6C). This reached the
level of arthritic animals without cell treatment (ﬁgure 6C). No
similar effects of 6OHDA were observed in control or
MSC-treated animals (see online supplementary ﬁgure S3B,
p=0.966 using general linear model; online supplementary
ﬁgure S3C, p=0.069 using general linear model).
DISCUSSION
For three decades, anti-inﬂammatory effects of catecholamines
such as norepinephrine are known when these neurotransmitters
operate via β-adrenoceptors (reviewed in27). Thus, the loss of sym-
pathetic nerve ﬁbres in inﬂamed tissue was interpreted as a
pro-inﬂammatory event.2 7 28 Importantly, concomitant to the loss
of sympathetic nerve ﬁbres there appear newly formed cells that
express TH, which we called TH+ cells or catecholaminergic
cells,9 10 but their role is unclear. While some authors hypothe-
sised that these cells have pro-inﬂammatory activities,29 TH+ cells
might have anti-inﬂammatory capacities when neurotransmitter
concentrations are high enough for β-adrenergic signalling.9
It was the starting point of the present work to ﬁnd mechan-
isms that can increase TH protein expression and function in
inﬂammatory cells in order to increase local catecholamine
levels. An important factor to increase TH expression is
hypoxia.18 19 30 31 In the present study, we demonstrated that
TH expression increased when mixed synovial cells of OA and
RA patients were incubated under hypoxic conditions. This con-
ﬁrms the work in other cell types.30 31 Hypoxia reduced TNF
levels in OA and RA synovial cells, downregulated IL-6/IL-8 in
OA, but upregulated IL-6/IL-8 in RA. While several studies
demonstrated differential results of hypoxia on various cyto-
kines,32 33 this is similarly ambiguous in primary synovial cells
of RA and OA in our study (which are mainly macrophages and
ﬁbroblasts). At the moment, we have no conclusions why RA
and OA cells behave in such a different way.
In order to demonstrate the speciﬁc hypoxia effect of TH on
cytokine secretion, we blocked TH by the highly competitive
antagonist αmpT. These hypoxia-mediated effects were enhanced
when we used speciﬁc TH cofactors BH4 and Fe
2+, which are
known to optimise TH activity. TNF inhibition in OA/RA syn-
ovial cells by hypoxia was abrogated by αmpT demonstrating
speciﬁc effects via this catecholaminergic key enzyme. Similarly,
hypoxia-induced effects on IL-6 secretion in OA/RA synovial
cells were augmented with BH4 and Fe
2+ and, again, these
changes were eliminated by αmpT. These experiments support
hypoxia-induced effects on cytokines via an increase of TH.
Another important aspect in this research is determination of
environmental catecholamines in the proximity of TH+ cells
because high levels of norepinephrine are desired (β-adrenergic
anti-inﬂammatory effects). In earlier studies, we demonstrated
Figure 5 Catecholamine secretion and tyrosine hydroxylase (TH) expression in murine mesenchymal stem cell (mMSCs)-derived TH+ neuronal cells.
(A) Secretion of catecholamines (NE, norepinephrine; DA, dopamine) in media without cells (mMSC medium, TH medium) and in supernatants of
mMSCs and TH+ neuronal cells (n=8–10). Box plots are explained in legend to ﬁgure 1. (B) Targeted killing of TH+ neuronal cells by
6-hydroxydopamine (6OHDA) and detection of live/dead cells after 6OHDA treatment. (C) Western blot analysis of expression of TH in TH+ neuronal
cells compared with mMSCs. TH+ NC, TH+ neuronal cells.
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presence of catecholamines in cultures of synovial TH+ cells
(5.9 pmol/L, 0.5 and 1.0 nmol/L)9 11 and in perfusion culture of
synovial tissue (0.5–0.8 nmol/L).11 In order to improve the
detection of catecholamines, inhibitors of catecholamine degrad-
ing enzymes, MAO and COMT, were used (in addition to BH4
and Fe2+ treatment). Under these conditions, norepinephrine
levels rose to 10–100 nmol/L (10−7 mol/L). This indicates that
environmental conditions can exist, which lead to high neuro-
transmitter levels relevant for β-adrenergic signalling.
Importantly, by administration of MAO plus COMT blockers,
inhibitory effects of hypoxia on TNF secretion in OA and RA
cells was markedly increased, which indicates a speciﬁc catecho-
laminergic effect.
Results in vitro persuaded us to test effects of TH+ cells in
vivo in experimental arthritis in mice. Since these cells cannot
be separated by magnetic or ﬂuorescent sorting techniques (no
speciﬁc surface molecule), TH+ cells were generated using
murine MSCs as described previously for human MSCs.24 We
called these cells TH+ neuronal cells.
Injected TH+ neuronal cells were found in paws but also in
abdominal organs (lymph nodes, spleen, adrenal glands). The
presence of TH+ neuronal cells in the joints 24 h after cell injec-
tion demonstrates clearly that TH+ neuronal cells survive in
vivo, migrate and exert anti-inﬂammatory effects. The migration
of induced TH+ neuronal cells into lymph nodes and spleen
suggests an additional anti-inﬂammatory immune response con-
tributing to possible favourable local effects.
Importantly, cellular therapy with TH+ neuronal cells led to a
signiﬁcant reduction of inﬂammation, which remained stable
until the end of the observation period. One single injection of
TH+ neuronal cells was sufﬁcient to maintain anti-inﬂammatory
effects for a long period of time. Similarly, MSC-treated mice
developed milder arthritis conﬁrming earlier studies.34
However, MSCs act as key regulators of immune tolerance by
inducing the generation/activation of Treg cells and not via the
key enzyme of catecholamine production since these cells do
not express TH. Positive effects of TH+ neuronal cells and
MSC were conﬁrmed by H&E staining.
In order to show that TH+ neuronal cells are responsible for
milder arthritis, we depleted TH+ neuronal cells by treatment
with 6OHDA as demonstrated earlier.10 During these experi-
ments, a short decrease of arthritis score was observed during
injection of 6OHDA. We hypothesise that this effect is most
likely depending on acute catecholamine release from sympa-
thetic nerve ﬁbres and TH+ cells after 6OHDA injection, which
is termed the initial 6OHDA norepinephrine burst. Such a cat-
echolamine burst is well known after treatment with 6OHDA
(ﬂuffy coat, tachycardia, high activity). However, after this burst
period, arthritis symptoms became signiﬁcantly worse. These
experiments conﬁrm earlier experiments of our group in which
injection of 6OHDA increased arthritis score in the late phase
of CIA (approximately day 55).8 It is important to mention that
control animals and MSC-treated animals receiving 6OHDA did
not show worsening. In earlier experiments, we demonstrated
Figure 6 Generated tyrosine hydroxylase-positive (TH+) neuronal cells in experimental arthritis and organ distribution. (A) Detection of PKH26
prelabelled TH+ neuronal cells in paw joints, lymph nodes, spleen and adrenal gland of arthritic mice after intravenous injection. (B) Anti-inﬂammatory
effects of TH+ neuronal cells on clinical score of experimental arthritis after intravenous injection compared with control arthritic mice (n=14).
(C) Reversion of anti-inﬂammatory effects of TH+ neuronal cells by intraperitoneal treatment of arthritic mice with 6-hydroxydopamine (6OHDA)
(n=14). post-cell tr, days after adoptive transfer of TH+ neuronal cells; post-immun, days after immunisation.
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that 6OHDA ameliorates CIA when given before or until day 18
after immunisation, while CIA is aggravated when 6OHDA is
given after day 45.8 35 However, administration of 6OHDA
between day 18 and 45 had no effect (we called this interval
transition phase).35 Since we injected TH+ neuronal cells in this
transition phase and since we observed worsening effects of
6OHDA in the transition phase, it is most likely that 6OHDA
effects are speciﬁc through elimination of TH+ neuronal cells
that were given in the transition phase.
In conclusion, this study demonstrated hypoxia-induced upre-
gulation of TH. TH was responsible for inhibition of TNF in
OA and RA synovial cells demonstrating an anti-inﬂammatory
effect of increased TH function. Cellular therapy with TH+
neuronal cells demonstrated a clear anti-inﬂammatory inﬂuence
of these cells in experimental arthritis. In future studies, we will
target speciﬁc receptors (adrenergic and adenosinergic) in order
to elucidate underlying molecular mechanisms of hypoxia
driven TH-dependent anti-inﬂammatory phenomena in arthritis.
This will help in developing novel cell therapy options for
patients with RA.
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